Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Guangdong Provincial People's Hospital: Clinical Trials & FDA Approval Profile

Guangdong Provincial People's Hospital (Global / Institutional) sponsors 37 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 26 active protocols (14 recruiting now), 5 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.0%
Median Closed Enrollment vs National (145 pts)144 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Guangdong Provincial People's Hospital
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)37
Active Pipeline (Recruiting Now)26 (14)
Completed vs Stopped Early5 / 0 (0.0%)
Median Closed Actual Enrollment144 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Guangdong Provincial People's Hospital
Hospital Research SiteLocationShared Protocols
Guangdong Provincial People's HospitalGuangzhou19
The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, Guangdong2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Guangdong Provincial People's Hospital
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06451861Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AMLPhase IIRECRUITING
NCT04946734Effectivity and Safety of PFO Closure vs Medicine in Alleviating MigrainePhase IIIACTIVE NOT RECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Guangdong Provincial People's Hospital Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI